Ondine Biomedical (LON:OBI) Stock Price Down 11.2% – Should You Sell?

Shares of Ondine Biomedical Inc. (LON:OBI) were down 11.2% on Monday . The company traded as low as GBX 11.17 ($0.14) and last traded at GBX 11.44 ($0.14). Approximately 1,307,796 shares changed hands during mid-day trading, an increase of 178% from the average daily volume of 469,878 shares. The stock had previously closed at GBX 12.89 ($0.16).

Ondine Biomedical Stock Performance

The firm has a 50-day moving average of GBX 8.93 and a two-hundred day moving average of GBX 7.90. The firm has a market capitalization of £33.27 million, a P/E ratio of -400.00 and a beta of 0.10. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.